{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig","slug":"funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig","published_at":"2026-09-07T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19741516-funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19741516-funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biotech playbook breaks down in today’s funding environment and what it takes to build a lean virtual drug development company without institutional financing. Craig describes practical financing paths, hard truths about costs, and the tradeoffs that make a rare disease program investable through alternative ...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sa…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3359,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/funding-a-virtual-biotech-without-institutional-capital-with-sarcomatrix-s-david-craig.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}